NextCure
NXTC
NXTC
48 hedge funds and large institutions have $25.5M invested in NextCure in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 15 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
0.05% less ownership
Funds ownership: 4.82% → 4.77% (-0.05%)
29% less capital invested
Capital invested by funds: $36M → $25.5M (-$10.5M)
Holders
48
Holding in Top 10
–
Calls
$2K
Puts
$2K
Top Buyers
| 1 | +$914K | |
| 2 | +$729K | |
| 3 | +$523K | |
| 4 |
Renaissance Technologies
New York
|
+$98.2K |
| 5 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$73.1K |
Top Sellers
| 1 | -$1.07M | |
| 2 | -$897K | |
| 3 | -$581K | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$385K |
| 5 |
Two Sigma Advisers
New York
|
-$129K |